Smad2/3-Regulated Expression of DLX2 Is Associated with Radiation-Induced Epithelial-Mesenchymal Transition and Radioresistance of A549 and MDA-MB-231 Human Cancer Cell Lines-Reference-Cited by-同舟云学术

Smad2/3-Regulated Expression of DLX2 Is Associated with Radiation-Induced Epithelial-Mesenchymal Transition and Radioresistance of A549 and MDA-MB-231 Human Cancer Cell Lines

Published:2016-01-22 Issue:1 Volume:11 Page:e0147343
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Choi Yeo-Jin,Baek Ga-Young,Park Hae-Ran,Jo Sung-Kee,Jung Uhee

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference45 articles.

1. Cancer stem cells as a predictive factor in radiotherapy;TB Brunner;Semin Radiat Oncol,2012

2. Cancer stem cells, the epithelial to mesenchymal transition (EMT) and radioresistance: Potential role of hypoxia;DT Marie-Egyptienne;Cancer Lett,2013

3. Prospective identification of tumorigenic breast cancer cells;M Al-Hajj;Proc Natl Acad Sci USA,2003

4. Identification and expansion of the tumorigenic lung cancer stem cell population;A Eramo;Cell Death Differ,2008

5. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer;PC Hermann;Cell Stem Cell,2007

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DLX2 Is a Potential Immune-Related Prognostic Indicator Associated with Remodeling of Tumor Microenvironment in Lung Squamous Cell Carcinoma: An Integrated Bioinformatical Analysis;Disease Markers;2022-10-21

2. Non-tumorigenic epithelial breast cells and ionizing radiation cooperate in the enhancement of mesenchymal traits in tumorigenic breast cancer cells;Life Sciences;2022-10

3. GDF15 Contributes to Radioresistance by Mediating the EMT and Stemness of Breast Cancer Cells;International Journal of Molecular Sciences;2022-09-18

4. Ionizing Radiation Promotes Epithelial-Mesenchymal Transition Phenotype and Stem Cell Marker in The Lung adenocarcinoma: In Vitro and Bioinformatic Studies;CELL J;2022

5. SMAD3 Host and Tumor Profiling to Identify Locally Advanced Rectal Cancer Patients at High Risk of Poor Response to Neoadjuvant Chemoradiotherapy;Frontiers in Pharmacology;2021-12-24